Aimslbackground-Human herpesvirus type 6 (HHV-6) is the aetiological agent of exanthem subitum, and has also been linked with a variety of other diseases. The aim of this study was to investigate the role of HHV-6 in pneumonitis in children. Methods-Formalin fixed, paraffin wax embedded lung tissue from 33 children (age range two months to 16 years) who died with pneumonitis was subjected to immunohistochemical staining for HHV-6 using an avidin-biotin method. Results-Active HHV-6 infection was demonstrated in four children: a bone marrow transplant recipient with concomitant adenovirus infection, a patient with hepatitis of unknown aetiology, a patient with congenital anomalies, and a patient with congenital immunodeficiency. Conclusion-Accurate localisation of HHV-6 is possible in postmortem lung tissue. HHV-6 either alone or in combination with other pathogens may play a role in the development of pneumonitis. (7 Clin Pathol 1996;49:802-804) 
Human herpesvirus 6 (HHV-6) is a recently discovered virus that, on the basis of serological evidence, seems to infect most children by the age of three years.' However, the clinical manifestations of primary HHV-6 infection and reactivation have not been well defined, except for the report by Yamanishi et Very few data exist regarding the role of HHV-6 infection in paediatric interstitial pneumonitis. We therefore investigated the role of HHV-6 in the development of pneumonitis in both immunocompetent and immunocompromised paediatric patients ranging in age from two months to 16 years.
Methods
An average of eight paraffin wax blocks of lung tissue prepared at necropsy from each of 33 paediatric patients with any type of pneumonitis as a primary or contributing cause of death were retreived from the archives of the Department of Pathology, Children's Hospital of Wisconsin. All patients had died between 1991 and 1994.
Cases of both diagnosed and idiopathic pneumonitis were included. Cases were also subdivided according to age: less than two years for presumed primary infections and more than two years for presumed late primary or reactivation disease. One of the cases studied (case 4; tables 2 and 3) has been described in detail previously,6 but was independently selected by the criteria used here.
DETECTION OF Immunohistochemical staining for the identification of HHV-6 infected cells based on an avidin-biotin system (Vector Laboratories, Burlingame, California, USA) has been described in detail by Russler et al. 7 The primary antibody used was a rabbit hyperimmune serum specific for cells actively infected with HHV-6. The alkaline phosphatase enzyme was used with a Vector Red reaction substrate and haematoxylin counterstain.
A negative control of each section was run in parallel with pre-immune serum from the same rabbit used for production of the HHV-6 specific antiserum. A positive control consisted of lung tissue from a young male bone marrow transplant recipient who died of fulminant HHV-6 pneumonitis. Internal controls of normal lung tissue, cytomegalovirus (CMV) infected lung tissue and adenovirus infected lung tissue, from patients who had these viruses isolated from necropsy lung tissue, were used as negative controls and proof against crossreactivity of the antibody. Lack of crossreactivity of the rabbit antiserum has also been shown previously.6 HHV-6 infected cells were counted and the number of infected cells per cm2 was calculated. Measurement of the size of the tissue sections in cm' excluded regions that were acellular or necrotic.
Determination of HHV-6 infected cell types was accomplished by double immunohistochemical staining, which has been described previously.8 Briefly, the rabbit antiserum was used first with an alkaline phosphataseNector Red substrate (fig 1) . Then, cell type specific monoclonal antibodies were used with a horseradish peroxidase/Vector SG substrate. The cell type specific primary antibodies used were: mouse anti-human macrophage (CD68); mouse anti-human epithelial membrane antigen (EMA); and mouse anti-human T cell phages, on the basis of their reactivity with the appropriate monoclonal antibody. The numbers of lymphocytes and macrophages infected were roughly equal, with no epithelial cell involvement detected.
The cause of death in two of the four patients infected with HHV-6 was identified as respiratory failure in cases 1 and 4, as hepatic necrosis in case 2, and as systemic adenovirus infection in case 3.
Two of the four patients with HHV-6 infection were known to be immunocompromised, either because of bone marrow transplantation or congenital immune deficiency. The clinical features of the patients are presented in table 3. Potential pathogens identified at the time of death are listed in table 4.
Discussion
This study demonstrates that some cases of idiopathic interstitial pneumonitis are probably caused by active HHV-6 infection. Comparing the rate of positive HHV-6 cases (n = 4) with those of CMV (n = 4), currently one of the most common causes of interstitial pneumonitis in the immunocompromised patient, we found equal rates of positivity (table 4) .
Two of the four patients infected with HHV-6 were known to be immunocompromised. The remaining "competent" patients had no known immunodeficiencies, but could have been functionally compromised by nutritional status or other factors. Although data are limited, this study suggests that HHV-6 infection has no preference for host immune state in the paediatric patient. The otherwise healthy child can acquire serious and fatal primary infection (for example, case 2) as readily as the immunocompromised patient.
Three of the four patients with HHV-6 infection were less than two years old, suggesting primary infections. One case in a three and a half year old child is suggestive of reactivation disease. However, no serologies were available on any of the patients studied, preventing determination of HHV-6 immune status. The three children with primary infections also had high levels of HHV-6 infected cells/cm'. One apparently immunocompetent child (case 2), most likely developed severe HHV-6 pneumonitis and hepatitis. As HHV-6 was identified in the lung, it can be speculated that the liver dysfunction in this patient was also the result of a HHV-6 infection.9 10 A severe primary HHV-6 infection was also present in case 4. However, in this case it is hypothesised that congenital HHV-6 infection resulted in immunodeficiency with eventual HHV-6 pneumonitis. This case has been described in detail previously.6 Case 1 was also an apparently immunocompetent child with severe primary HHV-6 infection. Staphylococcus aureus pneumonia was diagnosed at necropsy. The S aureus infection may have been secondary to the HHV-6 infection, as HHV-6 infection can severely compromise the function of phagocytic leucocytes."
In the three and a half year old child with a low level of HHV-6 infection (29 HHV-6 infected cells per cm' of tissue) HHV-6 infection probably reactivated as a result of Until easier ways of detecting HHV-6 become available, and testing is not restricted to research laboratories, the prevalence of disease will be underestimated. 
